{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:19:04Z","timestamp":1787026744931,"version":"build-2736575974"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Postural instability\/gait difficulty (PIGD) subtype in Parkinson\u2019s disease (PD) portends poorer prognosis and limited treatment response. While cerebral small vessel disease (CSVD) is implicated in motor impairment, its specific association with PIGD remains underexplored. This study aims to investigate the correlation between the severity of CSVD and PIGD subtype in PD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This cross-sectional study enrolled 161 PD patients (mean age 71.14\u202f\u00b1\u202f7.04\u202fyears). Motor subtyping [postural instability and gait difficulty (PIGD)\/tremor-dominant (TD)\/intermediate type (IT)] used MDS-UPDRS-derived ratios. CSVD burden was quantified via two validated MRI-based scores: the total CSVD burden score (range 0\u20134) and modified CSVD burden score (range 0\u20136). Multivariate logistic regression analysis, which adjusted for age, gender, disease duration, and vascular risk factors, was used to explore the correlation between CSVD burden and PIGD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The prevalence of PIGD was 49.07% (\n                      <jats:italic>n<\/jats:italic>\n                      \u202f=\u202f79). PIGD patients exhibited a significantly higher CSVD burden than the TD and IT groups (total score: 1.84\u202f\u00b1\u202f0.72 vs. 1.4\u202f\u00b1\u202f0.59 vs.1.15\u202f\u00b1\u202f0.49; modified score: 2.55\u202f\u00b1\u202f1.20 vs. 1.85\u202f\u00b1\u202f0.7 vs. 1.75\u202f\u00b1\u202f0.91, both\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). After full adjustment, each 1-point increase in total CSVD burden score associated with 7.16-fold higher PIGD odds (aOR\u202f=\u202f7.16, 95%CI\u202f=\u202f1.64\u201330.82,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.009), and each 1-point increase in modified CSVD burden score associated with 6.03-fold higher PIGD odds (aOR\u202f=\u202f6.03, 95%CI\u202f=\u202f3.06\u201311.90,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Global CSVD burden was independently associated with the occurrence of PIGD in PD. CSVD assessment may help identify PD patients at the highest risk for axial motor disability, highlighting the convergence of vascular and neurodegenerative pathologies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnagi.2025.1686214","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:05:22Z","timestamp":1764677122000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Correlation between cerebral small vessel disease and postural instability\/gait difficulty subtype in Parkinson\u2019s disease patients"],"prefix":"10.3389","volume":"17","author":[{"given":"Yingchao","family":"Ge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wa","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaorong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchao","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiting","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouru","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1093\/cvr\/cvy113","article-title":"Understanding the role of the perivascular space in cerebral small vessel disease","volume":"114","author":"Brown","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1212\/WNL.0000000000007654","article-title":"CNS small vessel disease","volume":"92","author":"Cannistraro","year":"2019","journal-title":"Neurology"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10072-022-06563-1","article-title":"The impact of cerebral small vessel disease burden and its imaging markers on gait, postural control, and cognition in Parkinson\u2019s disease","volume":"44","author":"Chen","year":"2023","journal-title":"Neurol. Sci."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.parkreldis.2020.12.025","article-title":"Cerebral small vessel disease may worsen motor function, cognition, and mood in Parkinson's disease","volume":"83","author":"Chen","year":"2021","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/mdc3.13003","article-title":"White matter hyperintensities mediate impact of dysautonomia on cognition in Parkinson's disease","volume":"7","author":"Dadar","year":"","journal-title":"Mov. Disord. Clin. Pract."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"7136","DOI":"10.3390\/ijms23137136","article-title":"The role of Immunosenescence in cerebral small vessel disease: a review","volume":"23","author":"Del Cuore","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/S1474-4422(23)00131-X","article-title":"Neuroimaging standards for research into small vessel disease-advances since 2013","volume":"22","author":"Duering","year":"2023","journal-title":"Lancet Neurol."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1159\/000540639","article-title":"Motor function is associated with cerebral small vessel disease and can predict mortality and poor functional outcome","volume":"54","author":"Hosoya","year":"2024","journal-title":"Cerebrovasc. Dis."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1002\/ana.26615","article-title":"Cerebral small vessel disease progression increases risk of incident parkinsonism","volume":"93","author":"Jacob","year":"2023","journal-title":"Ann. Neurol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1136\/jnnp.2006.103549","article-title":"Risk factor profile of cerebral small vessel disease and its subtypes","volume":"78","author":"Khan","year":"2006","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1212\/WNL.0000000000004042","article-title":"Total small vessel disease score and risk of recurrent stroke","volume":"88","author":"Lau","year":"2017","journal-title":"Neurology"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"10441","DOI":"10.2147\/JIR.S488600","article-title":"The level of fibrinogen-to-albumin ratio was associated with the severity of cerebral small vessel disease in patients with transient ischemic attack","volume":"17","author":"Liu","year":"2024","journal-title":"J. Inflamm. Res."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1212\/WNL.0000000000002091","article-title":"Parkinsonism, small vessel disease, and white matter disease: is there a link?","volume":"85","author":"Luca","year":"2015","journal-title":"Neurology"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1002\/acn3.51913","article-title":"Glycated hemoglobin A1c, cerebral small vessel disease burden, and disease severity in Parkinson's disease","volume":"10","author":"Ma","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"110441","DOI":"10.1016\/j.ejrad.2022.110441","article-title":"The interplay between small vessel disease and Parkinson disease pathology: a longitudinal study","volume":"154","author":"Mao","year":"2022","journal-title":"Eur. J. Radiol."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/17474930221144911","article-title":"Cerebral small vessel disease: recent advances and future directions","volume":"18","author":"Markus","year":"2023","journal-title":"Int. J. Stroke"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1002\/mds.25179","article-title":"Parkinson's disease and the risk of cerebrovascular pathology","volume":"27","author":"Morley","year":"2012","journal-title":"Mov. Disord."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1494","DOI":"10.1001\/jamaneurol.2021.3996","article-title":"Association of White Matter Hyperintensities with Pathology and Progression of parkinsonism in aging","volume":"78","author":"Oveisgharan","year":"2021","journal-title":"JAMA Neurol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/S1474-4422(10)70104-6","article-title":"Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges","volume":"9","author":"Pantoni","year":"2010","journal-title":"Lancet Neurol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"4958","DOI":"10.3390\/ijms22094958","article-title":"The contribution of small vessel disease to neurodegeneration: focus on Alzheimer\u2019s disease, Parkinson\u2019s disease and multiple sclerosis","volume":"22","author":"Paolini Paoletti","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"ref21","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.nicl.2013.06.006","article-title":"Impact of regional cortical and subcortical changes on processing speed in cerebral small vessel disease","volume":"2","author":"Righart","year":"2013","journal-title":"Neuroimage Clin."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/gerona\/glz161","article-title":"Influence of striatal dopamine, cerebral small vessel disease, and other risk factors on age-related parkinsonian motor signs","volume":"75","author":"Rosano","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e213438","DOI":"10.1212\/WNL.0000000000213438","article-title":"Association of plasma biomarkers with longitudinal atrophy and microvascular burden on MRI across neurodegenerative and cerebrovascular diseases","volume":"104","author":"Sanchez","year":"2025","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/svn-2016-000035","article-title":"Update on cerebral small vessel disease: a dynamic whole-brain disease","volume":"1","author":"Shi","year":"2016","journal-title":"Stroke Vasc. Neurol."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1212\/WNL.0000000000000837","article-title":"Stroke subtype, vascular risk factors, and total MRI brain small-vessel disease burden","volume":"83","author":"Staals","year":"2014","journal-title":"Neurology"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1111\/cns.14047","article-title":"Plasma inflammatory biomarkers in cerebral small vessel disease: a review","volume":"29","author":"Wan","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"ref27","doi-asserted-by":"publisher","first-page":"288","DOI":"10.21037\/atm-22-276","article-title":"Effect of cerebral small vessel disease on cognitive impairment in Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"10","author":"Wan","year":"2022","journal-title":"Ann. Transl. Med."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"105386","DOI":"10.1016\/j.parkreldis.2023.105386","article-title":"Disturbance of functional brain networks and cognitive decline in Parkinson's disease: severe cerebral small vessel disease aggravates this relationship","volume":"110","author":"Wan","year":"2023","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","article-title":"Small vessel disease: mechanisms and clinical implications","volume":"18","author":"Wardlaw","year":"2019","journal-title":"Lancet Neurol."},{"key":"ref31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.parkreldis.2018.10.008","article-title":"Is hyperhomocysteinemia associated with the structural changes of the substantia nigra in Parkinson's disease? A two-year follow-up study","volume":"60","author":"Zhang","year":"2019","journal-title":"Parkinsonism Relat. Disord."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1686214\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T12:05:23Z","timestamp":1764677123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1686214\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":31,"alternative-id":["10.3389\/fnagi.2025.1686214"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2025.1686214","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"article-number":"1686214"}}